| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.006 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |